Study Summary:
We are currently conducting a 24-week, randomized, double-blind, placebo controlled safety and efficacy trial of an investigational medication for hypoactive sexual desire disorder in pre-menopausal women.
Qualified Participants Must:
• Have regular menses
•
Be in a stable, monogamous, heterosexual relationship for at least 1 year
•
Not be taking anti-depressants or anti-anxiety medications
Qualified Participants May Receive:
Compensation for time and travel ($50) per study visit.